German court rebuffs GSK on Advair patent - FiercePharma
Links shared publicly online about this topic.
- 1,155total visits
German court rebuffs GSK on Advair patent - FiercePharma
A German patent court in Munich has determined that a key patent on GlaxoSmithKline's (NYSE: GSK) lung drug Advair (aka Viani) is not valid, dealing a blow to the top-selling lung drug in Europe's... Read more...
View full resource at fiercepharma.com
Tags: Asthma Medication, Lung, COPD Medication, Drug, Advair, GlaxoSmithKline
Most Recently Shared on May 20, 2010 at 3:10 pm By:
German court rebuffs GSK on Advair patent. http://bit.ly/9R4eyc
Advertisement
